Regarding the leptin levels, it has been demonstrated that TZDs reduced the leptin expression in adipose tissue, which could counteract the enhancement of leptin levels due to the TDZs-induced adipose tissue increase, with a neutral effect of TZDs on circulating leptin levels in NASH patients [8]. Here, LEP is linked to metabolic dysfunction-associated steatohepatitis.